AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 48 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,644,410 | -20.9% | 1,963,479 | 0.0% | 0.15% | -21.0% |
| Q2 2023 | $33,673,665 | -15.0% | 1,963,479 | 0.0% | 0.20% | -9.3% |
| Q1 2023 | $39,603,371 | -31.6% | 1,963,479 | -0.7% | 0.22% | -38.2% |
| Q4 2022 | $57,922,232 | +76.5% | 1,976,868 | -0.1% | 0.35% | +61.9% |
| Q3 2022 | $32,821,000 | +1.4% | 1,979,568 | -4.4% | 0.22% | +16.8% |
| Q2 2022 | $32,354,000 | -14.7% | 2,070,010 | 0.0% | 0.18% | -15.6% |
| Q1 2022 | $37,943,000 | +75.7% | 2,070,010 | +13.0% | 0.22% | +107.6% |
| Q4 2021 | $21,597,000 | -37.7% | 1,831,789 | +10.9% | 0.10% | -30.9% |
| Q3 2021 | $34,663,000 | +6.3% | 1,652,171 | +15.7% | 0.15% | +6.3% |
| Q2 2021 | $32,614,000 | – | 1,428,571 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $17,690,227 | 28.88% |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59,113,365 | 7.12% |
| Sofinnova Investments, Inc. | 3,758,686 | $110,129,500 | 6.54% |
| TCG Crossover Management, LLC | 1,081,274 | $31,681,328 | 5.59% |
| RA Capital Management | 8,263,982 | $242,134,673 | 4.91% |
| Cormorant Asset Management, LP | 1,957,132 | $57,344 | 3.84% |
| VR Adviser, LLC | 747,869 | $21,912,562 | 3.69% |
| Octagon Capital Advisors LP | 621,712 | $18,216,162 | 2.84% |
| GREAT POINT PARTNERS LLC | 378,522 | $11,090,695 | 2.17% |
| Ghost Tree Capital, LLC | 135,000 | $3,956,000 | 1.69% |